arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Drugs Made In America Acquisition II Corp.

DMII
$10.22 0.00 (0.00%) at close
Financials ·Blank Checks ·USBlank Checks
2 Visible periods
11 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Neutral
auto_awesome

Analytical Summary

Drugs Made In America Acquisition II Corp. shows mixed fundamentals. Consider comparing against peers in the Financials sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 2.2%
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 4, 2026.

Health Breakdown

Returns
26
Cash Quality
16

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 2 years · 8 quarters